Seer Inc at JPMorgan Healthcare Conference Transcript
All right. Good morning, everyone. This is Julia Qin from the life science team at JPMorgan. It's my great pleasure to introduce you to our next presentation by Seer. As a reminder, if you have a question, you can submit it through the website. And with that, let me turn it over to Omid.
Good morning, everyone, and thanks so much, Julia, Tycho and the JPMorgan team for the opportunity to present today. I'm Omid Farokhzad, CEO and Founder of Seer, a company which I founded back in 2017 and went public in December of 2020. I'm going to walk you through some of the foundational aspects of our company, the progress we've made in our first year as a public company and share with you why we believe Seer is leading the proteomics revolution. My presentation today will be followed by a Q&A with myself and David Horn, our Chief Financial Officer.
Now please note our safe harbor disclosure, which indicates that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |